Market Overview
The global Fertility and Pregnancy Rapid Test Kits market was valued at USD 598 million in 2024 and is projected to reach USD 734 million by 2031, exhibiting a CAGR of 3.0% during the forecast period.
Fertility and pregnancy rapid test kits are point-of-care diagnostic devices designed for the qualitative detection of key reproductive hormones. These include Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), and Human Chorionic Gonadotropin (hCG). For fertility applications, these tests help identify ovulation peaks in women, assess sperm count in men, and confirm menopause onset. Pregnancy tests specifically detect hCG to confirm pregnancy. The tests utilize lateral flow immunoassay technology, providing results within minutes from small urine or blood samples.
USD 598 million in 2024
2032 USD 734 million by 2031
CAGR of 3.0%
Ovulation Prediction Kits
Pregnancy Test Kits
Ovulation Prediction Kits lead in driving market growth due to increasing demand for fertility tracking among couples trying to conceive, while pregnancy tests maintain steady demand from both planned and unexpected pregnancy scenarios.
Home Testing
Clinical Settings Fertility
Home
https://www.24lifesciences.com
Our Key Players
Swiss Precision Diagnostics (Switzerland)
Siemens Healthineers (Germany)
QuidelOrtho Corporation (USA)
Becton Dickinson and Company (USA)
Danaher Corporation (USA)
SMB Corporation (India)
